Home > Products > CD3 & IL2R > Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (scFv4-Ig)

Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (scFv4-Ig)  (CAT#: FVTIG-093)

Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (scFv4-Ig) is an appended IgG format, which includes four scFv moieties at the N-termini of the constant regions. It is a bivalent homodimer, in which one anti-CD3 scFv is fused to the CH1 domain of a heavy chain and another anti-IL2R scFv to the CL domain of a light chain, or vice versa. The resulting leads to 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Hodgkin lymphoma; Non-Hodgkin's lymphoma (NHL); Acute lymphocytic leukemia (ALL) therapy.
Datasheet INQUIRY

Specifications

Targets
CD3 & IL2R
Type
Appended IgGs
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Hodgkin lymphoma; Non-Hodgkin's lymphoma (NHL); Acute lymphocytic leukemia (ALL)

Targets

Target 1
CD3
Gene ID
UniProt ID
Alternative Names
CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3
Target 2
IL2R
Gene ID
UniProt ID
Alternative Names
IL-2R; IL2R; Interleukin 2 receptor; p55; CD25; TCGFR; IDDM10; interleukin 2 receptor subunit alpha; IL2RA
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD3 & IL2R"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (scFv4-Ig) (FVTIG-093). Click the button below to contact us or submit your feedback about this product.